<?xml version="1.0"?>
<notificationOfRemoval>

    <schemaVersion>X0203</schemaVersion>

    <exchange>
        <cik>0001354457</cik>
        <entityName>NASDAQ Stock Market LLC</entityName>
    </exchange>

    <issuer>
        <cik>0000810084</cik>
        <entityName>BIOJECT MEDICAL TECHNOLOGIES INC</entityName>
        <fileNumber>000-15360</fileNumber>
        <address>
            <street1>20245 S.W. 95th Avenue</street1>
            <street2></street2>
            <city>Tualatin</city>
            <stateOrCountryCode>OR</stateOrCountryCode>
            <stateOrCountry>OREGON</stateOrCountry>
            <zipCode>97062</zipCode>
        </address>
        <telephoneNumber>503-692-8001</telephoneNumber>
    </issuer>

    <descriptionClassSecurity>Common stock</descriptionClassSecurity>

    <ruleProvision>17 CFR 240.12d2-2(b)</ruleProvision>

    <signatureData>
        <signatureName>Amy Horton</signatureName>
        <signatureTitle>Associate General Counsel</signatureTitle>
        <signatureDate>2008-10-07</signatureDate>
    </signatureData>
</notificationOfRemoval>
